| 國立臺北護理健康大學 |
1992 |
Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective
|
Charak, BS;Agah, R;Brynes, RK;Chogyoji, M;Groshen, S;Chen, SC;Mazumder, A |
| 中國醫藥大學 |
2008-03-29 |
Interleukin-2 Expression Involved in the Antizyme-mediated Immuno-modulation
|
曾秀學(H.H. Tseng); (Y.F. Liao); (G.R You); (G.Y. Liu); 高銘欽(Ming-Ching Kao)* |
| 國立臺灣大學 |
1990 |
Interleukin-2 Immunotherapy in Children
|
Chien, C. H.; 謝貴雄; Chien, C. H.; Hsieh, Kue-Hsiung |
| 國立交通大學 |
2014-12-08T15:18:38Z |
Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis
|
Hsieh, YY; Chang, CC; Tsai, FJ; Hsu, CM; Lin, CC; Tsai, CH |
| 中國醫藥大學 |
2005 |
Interleukin-2 receptor beta (IL-2R beta)-627*C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis
|
Hsieh, YY; Chang, CC; Tsai, FJ; Hsu, CM; Lin, CC; Tsai, CH |
| 亞洲大學 |
2006-08 |
Interleukin-2 receptor gene polymorphism in Chinese patients with systemic lupus erythematosus
|
Chang-Hai Tsai;Chung-Ming Huang;Lo Sui Foon;Lei Wan;Fuu-Jen Tsai |
| 中國醫藥大學 |
2006-08 |
Interleukin-2 receptor gene polymorphism in Chinese patients with systemic lupus erythematosus
|
蔡長海(Chang-Hai Tsai); 黃春明(Chung-Ming Huang); 羅瑞寬(Lo Sui Foon); 萬磊(Lei Wan); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2005-08 |
Interleukin-2 receptor β (IL-2Rβ)-627*C homozygote but not IL-12Rβ1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis
|
謝耀元(Yao-Yuan Hsieh); 張其真(Chi-Chen Chang); 蔡輔仁(Fuu-Jen Tsai)*; 許欽木(Chin-Mu Hsu); 林正介(Cheng-Chieh Lin); 蔡長海(Chang-Hai Tsai) |
| 亞洲大學 |
2005-08 |
Interleukin-2 receptor β(IL-2Rβ)-627*C homozygote but not IL-12Rβ1 codon 378 or IL-18 105 polymorphish is associated with higher susceptibility to endometriosis
|
Yao-Yuan Hsieh;Chi-Chen Chang;Fuu-Jen Tsai;Chin-Mu Hsu;Cheng-Chieh Lin;Chang-Hai Tsai |
| 國立成功大學 |
2011-05 |
Interleukin-20 antibody is a potential therapeutic for rheumatoid arthritis
|
Hsu, Yu-Hsiang; Chang, Ming-Shi |
| 國立成功大學 |
2008-07 |
Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure
|
Li, Hsing-Hui; Hsu, Yu-Hsiang; Wei, Chi-Chen; Lee, P. T.; Chen, Wen-Chung; Chang, Ming-Shi |
| 國立成功大學 |
2008-09 |
Interleukin-20 induced cell death in renal epithelial cells and was associated with acute renal failure
|
Li, Hsing-Hui; Chang, Ming-Shi |
| 國立成功大學 |
2022-06-9 |
Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
|
Wang;Hsiao-Hsuan;Chen;Wei-Yu;Huang;Yi-Hsun;Hsu;Sheng-Min;Tsao;Yeou-Ping;Hsu;Yu-Hsiang;Chang;Ming-Shi |
| 國立成功大學 |
2006-04 |
Interleukin-20 promotes angiogenesis in a direct and indirect manner
|
Hsieh, Mei-Yi; Chen, Wei-Yu; Jiang, Meei-Jyh; Cheng, Bor-Chih; Huang, Tsuei-Yuan; Chang, Ming-Shi |
| 國立成功大學 |
2008-09-26 |
Interleukin-20 targets renal cells and is associated with chronic kidney disease
|
Wei, Chi-Chen; Li, Hsing-Hui; Hsu, Yu-Hsiang; Hsing, Chung-Hsi; Sung, Junne-Ming; Chang, Ming-Shi |
| 國立成功大學 |
2008-11 |
Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis
|
Li, Hsing-Hui; Cheng, He-Hsiung; Sun, Kuang-Hui; Wei, Chi-Chen; Li, Chien-Feng; Chen, Wen-Chung; Wu, Wen-Mein; Chang, Ming-Shi |
| 國立臺灣大學 |
2015 |
Interleukin-21 suppresses the differentiation and functions of T helper 2 cells
|
Lin, Pin-Yi; Jen, Hsiao-Yu; Chiang, Bor-Luen; Sheu, Fuu; Chuang, Ya-Hui; 莊雅惠; 江伯倫 |
| 臺大學術典藏 |
2020-07-01T06:54:59Z |
Interleukin-21 suppresses the differentiation and functions of T helper 2 cells
|
Lin P.-Y.;Jen H.-Y.;Chiang B.-L.;Sheu F.;Ya-Hui Chuang; Lin P.-Y.; Jen H.-Y.; Chiang B.-L.; Sheu F.; YA-HUI CHUANG |
| 臺大學術典藏 |
2021-07-02T03:41:33Z |
Interleukin-21 suppresses the differentiation and functions of T helper 2 cells
|
Lin P.-Y.; Jen H.-Y.; BOR-LUEN CHIANG; Sheu F.; Chuang Y.-H. |
| 國立成功大學 |
2022-09 |
Interleukin-23 Mediates Osteoclastogenesis in Collagen-Induced Arthritis by Modulating MicroRNA-223
|
Chen;Shih-Yao;Tsai;Ting-Chien;Li;Yuan-Tsung;Ding;Yun-Chiao;Wang;Chung-Teng;Hsieh;Jeng-Long;Wu;Chao-Liang;Wu;Po-Ting;Shiau;Ai-Li |
| 中山醫學大學 |
2012 |
Interleukin-23 receptor polymorphism as a risk factor for oral cancer susceptibility.
|
Chien, MH; Hsin, CH; Chou, LS; Chung, TT; Lin, CH; Weng, MS; Chou, MY; Chen, MK; Yang, SF |
| 國家衛生研究院 |
2017-06-01 |
Interleukin-24 as a target cytokine of environmental aryl hydrocarbon receptor agonist exposure in the lung
|
Luo, YH;Kuo, YC;Tsai, MH;Ho, CC;Tsai, HT;Hsu, C;Chen, YC;Lin, P |
| 國立成功大學 |
2021-02 |
Interleukin-24 protects against liver injury in mouse models
|
Wang;Hsiao-Hsuan;Huang;Jian-Hao;Sue;Min-Hao;Ho;Wei-Chih;Hsu;Yu-Hsiang;Chang;Kung-Chao;Chang;Ming-Shi |
| 國立臺灣大學 |
2015 |
Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
|
Wang, Wei-Bei; Yen, Men-Luh; Liu, Ko-Jiunn; Hsu, Pei-Ju; Lin, Ming-Hong; Chen, Pei-Min; Sudhir, Putty-Reddy; Chen, Chein-Hung; Chen, Chung-Hsuan; Sytwu, Huei-Kang; Yen, B. Linju; 嚴孟祿 |
| 臺大學術典藏 |
2020-02-11T01:43:52Z |
Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
|
Wang W.-B; MEN-LUH YEN; Liu K.-J; Hsu P.-J; Lin M.-H; Chen P.-M; Sudhir P.-R; Chen C.-H; Sytwu H.-K; Yen B.L. |
